查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197137

痔瘡治療設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Hemorrhoid Treatment Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

痔瘡治療設備市場預計在預測期內（2022 年至 2027 年）的複合年增長率為 4.7%。

COVID-19 大流行是一個前所未有的健康問題，對世界各地的社區、工業、企業和生計產生了負面影響。 全球越來越多的 COVID-19 病例對市場產生了重大影響。 例如，2020 年 10 月發表的一項題為“COVID-19 檢疫對晚期痔瘡疾病的影響以及遠程醫療在患者管理中的作用”的研究發現，與 COVID-19 相關的延誤與痔瘡症狀和患者健康有關據說會導致惡化。 體重減輕和生活方式的改變是決定疾病嚴重程度的重要因素。 因此，COVID-19 對市場增長產生了顯著影響。

痔瘡是腫脹組織內腫脹、擴張的血管異常腫塊，發生在肛管內或肛門外，其特徵是出血、疼痛和瘙癢。 痔瘡形成於直腸內部（內痔）或肛門周圍皮膚下（外痔）。 有針對痔瘡的有效治療方法，例如束帶固定器和雙極探針，但大多數人在家庭治療和生活方式改變後都會感到寬慰。

此外，研究的增加是推動市場增長的主要因素之一。 例如，2021 年 4 月發表的一項題為“埃塞俄比亞西北部貢德爾大學綜合專科醫院外科門診成年患者痔瘡患病率及相關因素”的研究發現，痔瘡的總體患病率很高。其在男性受試者中的患病率很高。 已發現便秘和超重會增加患痔瘡的機率。 衛生專業人員尤其是高危人群更容易進行痔瘡早期檢測和乾預篩查。 因此，越來越多的診斷將導致對治療的需求增加，這將成為未來市場增長的驅動力。

預計臨床試驗的增加也將推動市場增長。 例如，一項名為“內鏡治療痔瘡的比較研究（METHOD）：一項多中心隨機對照臨床試驗”的臨床研究由王方宇發起，於2022年5月開始，2025年1月完成。預計一個月內完成。 檢查每種此類設備有效性的研究可能會導致未來在治療痔瘡時使用新設備，這有望推動市場增長。

因此，由於上述因素，市場有望在預測期內出現增長。 然而，多種藥物作為替代治療選擇的可用性可能會阻礙未來的市場增長。

痔瘡治療設備的市場趨勢

Bundligator有望佔據痔瘡治療器械市場主要份額

由於目標疾病負擔增加、研究增加以及市場參與者推出新產品，預計在預測期內 Bandligators 將出現增長。 對於內痔和嚴重的痔瘡，Bandligator 在治療結果和療效方面提供了一個優越的解決方案。

各種研究證明了該設備在不同階段的治療效果，從而加速了綁帶鉗的採用並促進了細分市場的增長。 例如，在 2021 年 3 月發表的一項題為“橡皮筋結紮與痔切除術治療 II-III 級痔瘡：隨機對照試驗的系統評價和薈萃分析”的研究中，肛瘺與更好的症狀控制相關。但以更多的疼痛和並發症為代價。 對於 II-III 級痔瘡患者，痔切除術比橡皮筋結紮術能更好地控制症狀，但術後疼痛和並發症更多。 像這樣的研究已經證明，橡皮筋結紮手術比其他儀器具有更少的並發症，這正在促進該領域的發展。

此外，產品發布也有望推動該細分市場的增長。 例如，2020 年 8 月，Micro-Tech Endoscopy USA 推出了 In-Sight Multi-Band Ligator，這是其止血產品組合中的一款新產品。 In-Sight 專為 I、II 和 III 級內痔的門診非內窺鏡治療而設計。 此類產品的推出預計將推動該細分市場的增長。

因此，由於上述因素，該市場有望在預測期內呈現增長。

預計北美將佔據很大的市場份額，預計在預測期內也會如此

北美有望在痔瘡治療設備市場佔據重要市場份額，因為該地區對先進治療方案的可用性、更好的報銷政策以及新產品的快速商業化的認識不斷提高。.

根據 2021 年 4 月發表的一篇題為“埃塞俄比亞西北部貢德爾大學綜合專科醫院外科門診成年患者痔瘡的患病率和相關因素”的 PLOS ONE 期刊文章，痔瘡在美國很普遍據報導，它是第四大最常見的門診胃腸道診斷，約有 330 萬門診就診。 如此高的疾病負擔預計將推動該地區的市場增長。

此外，繃帶結紮術是該地區治療出血性內痔疾病最常用的方法之一。 這些設備的產品發布一直是推動市場增長的因素之一。 例如，2020 年 3 月，Micro-Tech Endoscopy 為其止血產品組合推出了一款新產品 In-Sight Multi-Band Ligator。 In-Sight 專為 I、II 和 III 級內痔的門診非內窺鏡治療而設計。

此外，多項研究強調這些方法使用起來是安全的。 例如，2020 年 2 月，一項名為“橡皮筋結紮術對出血性內痔的影響”的臨床試驗，旨在檢驗橡皮筋結紮術的效果。 本研究的目的是檢查在使用抗痔瘡藥物治療的出血性內痔中加入橡皮筋結紮術的有效性。 預計此類研究將推動市場的增長。 此外，痔瘡治療設備的技術進步和完善的醫療基礎設施為該地區市場的增長做出了重大貢獻。

因此，由於上述因素，預計北美地區的市場在預測期內將出現增長。

痔瘡治療器械市場競爭者分析

痔瘡治療設備市場是分散的，由幾家主要參與者組成。 從市場份額的角度來看，一些主要參與者主導著市場。 目前主導市場的公司包括 Boston Scientific Corporation、Medtronic Plc、Cook Medical、DePuy Synthes (Johnson & Johnson)、Integra LifeSciences Corporation、CONMED Corporation、Medline Industries, Inc、Surkon Medical、Sklar Surgical Instruments 和 Privi Medical。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 痔瘡患病率上升
    • 痔瘡治療設備技術進展
  • 市場製約因素
    • 多種藥物作為替代治療方案的可能性
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品類型
    • 綁匪
    • 雙極探頭
    • 激光探頭
    • 冷凍治療設備
    • 紅外凝固器
    • 硬化劑注射器
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • A.M.I. GmbH
    • Boston Scientific Corporation
    • CONMED Corporation
    • Cook Medical
    • DePuy Synthes（Johnson & Johnson）
    • Integra LifeSciences Corporation
    • Medline Industries, Inc
    • Medtronic Plc
    • obp Surgical Corporation
    • Privi Medical
    • Sklar Surgical Instruments
    • Surkon Medical Co., Ltd

第7章 市場機會與今後動向

簡介目錄
Product Code: 68008

The hemorrhoid treatment devices market is expected to register a CAGR of 4.7% during the forecast period (2022-2027).

The COVID-19 pandemic was an unprecedented health concern and adversely affected communities, industries, businesses, and lives worldwide. The rising COVID-19 cases across the globe have had a profound impact on the market. For instance, a research study titled "Impact of COVID-19 Quarantine on Advanced Hemorrhoidal Disease and the Role of Telemedicine in Patient Management", published in October 2020, stated that COVID-19-related delays are linked to a deterioration of hemorrhoidal symptoms and patients' well-being. Weight loss and lifestyle changes were deemed critical factors in determining disease severity. Thus, COVID-19 had a pronounced impact on the growth of the market.

A hemorrhoid is an abnormal mass of engorged and dilated blood vessels in swollen tissue that occurs internally in the anal canal or externally around the anus that may be characterized by bleeding, pain, or itching. Hemorrhoids can develop inside the rectum (internal hemorrhoids) or under the skin around the anus (external hemorrhoids). Some effective treatment options, such as band ligators and bipolar probes, are available for hemorrhoids, but most people get relief with home treatments and lifestyle changes.

Moreover, the growing number of research studies is one of the major factors driving the growth of the market. For instance, a research study titled "Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia" published in April 2021 stated that the overall prevalence of hemorrhoids was high, and its prevalence was higher in male subjects. Constipation and being overweight were found to increase the odds of having hemorrhoids. Screening for early identification and intervention of hemorrhoids, especially for high-risk groups, is better practiced by health professionals. Hence, the increasing diagnosis will lead to an increase in demand for treatment and thus drive market growth in the future.

The increasing number of clinical trials is also expected to propel the growth of the market. For instance, the clinical study titled "Comparative Study on Endoscopic Treatments for Hemorrhoids (METHOD): a Multicenter, Randomized Controlled Clinical Trial" was started in May 2022 and is expected to be completed by January 2025, sponsored by Fangyu Wang. Such studies to find out the effectiveness of the different devices may lead to the usage of new devices in the treatment of hemorrhoids in the future and thus are expected to impel the growth of the market.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the availability of several drugs as alternate treatment options will hinder market growth in the future.

Hemorrhoid Treatment Devices Market Trends

Band Ligators Segment is Expected to Hold a Major Market Share in the Hemorrhoid Treatment Devices Market

The band ligators segment is expected to show growth over the forecast period, owing to the rising burden of target disease, increasing research studies, and the launch of newer products by the market players. For internal and severe forms of hemorrhoids, band ligators offer better solutions than others in terms of outcomes and effectiveness in treatment.

Various research studies demonstrate the effectiveness of treatment with devices at different stages, thereby accelerating the adoption of band ligators and thus contributing to the growth of the market segment. For instance, a research study titled "Rubber band ligation versus haemorrhoidectomy for the treatment of grade II-III hemorrhoids: a systematic review and meta-analysis of randomized controlled trials" published in March 2021 stated that haemorrhoidectomy seems to provide better symptom control but at the cost of more pain and complications. Hemorrhoidectomy offers better symptom control than rubber band ligation in patients with grade II-III hemorrhoids but is accompanied by more postoperative pain and complications. Such studies demonstrate fewer complications associated with band ligators than with other devices, in turn fueling the segment's growth.

Furthermore, the launch of the products is also expected to propel the growth of the market segment. For instance, in August 2020, Micro-Tech Endoscopy USA launched a new product in its hemostasis portfolio, namely the In-Sight Multi-Band Ligator. In-Sight was designed for the office-based, non-endoscopic treatment of grade I, II, and III internal hemorrhoids. Such launches are expected to propel the growth of the segment.

Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the hemorrhoid treatment devices market due to increasing awareness about the availability of advanced treatment options, better reimbursement policies, and faster commercialization of novel products in this region.

According to the PLOS ONE Journal article titled "Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia" published in April 2021, reported that in the United States, hemorrhoid disease is the fourth leading outpatient gastrointestinal diagnosis, accounting for nearly 3.3 million ambulatory care visits. Such a high burden of diseases is expected to drive the growth of the market in the region.

Additionally, band ligation is one of the most frequently used methods in treating hemorrhagic internal hemorrhoidal disease in the region. Product launches with respect to these devices are one of the factors driving the growth of the market. For instance, in March 2020, Micro-Tech Endoscopy launched a new product in their hemostasis portfolio with the In-Sight Multi-Band Ligator. In-Sight was designed for the office-based, non-endoscopic treatment of grade I, II, and III internal hemorrhoids.

Furthermore, several studies have highlighted that these methods are safe to use. For instance, in February 2020, a clinical trial titled "The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids" studied the effect of rubber band ligation. Under this, the investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti-hemorrhoidal drug. Such studies are expected to propel the growth of the market. Moreover, technological advancements in hemorrhoid treatment devices and well-established healthcare infrastructure are also considerably fueling the regional market's growth.

Thus, owing to the abovementioned factors, the studied market in the North American region is expected to show growth over the forecast period.

Hemorrhoid Treatment Devices Market Competitor Analysis

The Hemorrhoid Treatment Devices Market is fragmented and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Boston Scientific Corporation, Medtronic Plc, Cook Medical, DePuy Synthes (Johnson & Johnson), Integra LifeSciences Corporation, CONMED Corporation, Medline Industries, Inc, Surkon Medical Co., Ltd, Sklar Surgical Instruments, and Privi Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Hemorrhoids
    • 4.2.2 Technological Advancements in Hemorrhoid Treatment Devices
  • 4.3 Market Restraints
    • 4.3.1 Availability of Several Drugs as an Alternate Treatment Option
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Band Ligators
    • 5.1.2 Bipolar Probes
    • 5.1.3 Laser Probes
    • 5.1.4 Cryotherapy Devices
    • 5.1.5 Infrared Coagulators
    • 5.1.6 Sclerotherapy Injectors
    • 5.1.7 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 A.M.I. GmbH
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 CONMED Corporation
    • 6.1.4 Cook Medical
    • 6.1.5 DePuy Synthes (Johnson & Johnson)
    • 6.1.6 Integra LifeSciences Corporation
    • 6.1.7 Medline Industries, Inc
    • 6.1.8 Medtronic Plc
    • 6.1.9 obp Surgical Corporation
    • 6.1.10 Privi Medical
    • 6.1.11 Sklar Surgical Instruments
    • 6.1.12 Surkon Medical Co., Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS